期刊文献+

长效胸腺五肽的合成 被引量:1

Synthesis of site-specific PEGylated thymopentin
下载PDF
导出
摘要 目的提高长效胸腺五肽(mPEG(10kD)-TP5)——定位单链聚乙二醇化修饰的胸腺五肽的合成产率。方法选用Fmoc-Tyr(tBu)-Wang树脂和Fmoc/t-Butyl策略完成所有氨基酸的缩合,三氟乙酸对Wang树脂、侧链切割脱除。在碱性条件下,单甲氧基聚乙二醇修饰物(mPEG(10kD)-SPA)定点连接到赖氨酸的侧链氨基(ε-NH2)上。中间产物经钯碳催化氢化,得到mPEG(10kD)-TP5。结果目标产物总收率为20%,新合成路线比我们之前报道的方法产率提高了10倍。结论路线操作简单,易于纯化,产率较高。 Purpose To enhance the yield of site-specific PEGylated(10KD) thymopentin. Methods All the amino acids were step-wise assembled on Fmoc-Tyr(tBu)-wang resin by Fmoc/t-Butyl strategy. Then the Wang resins were cleaved and the side-chains were removed through treatment with trifluoracetic acid. Under alkalescent conditions,the mono-PEGylation was targeted to the ε-amine group of the lysine. The pegylated thymopentin was made by Pd/C catalytic hydrogenation. Results The total yield was 20% , which was improving for 10 times in comparison with the yield reported by us. Conclusion This method is easily handing with high yield and low cost for preparing pegylated TPS.
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2012年第5期609-611,614,共4页 Chinese Journal of Biochemical Pharmaceutics
关键词 胸腺五肽 定点聚乙二醇化 合成 thymopentin site-specific PEGylation synthesis
  • 相关文献

参考文献8

  • 1Tischio J P,Patrick J E,Weintraub H S,et al.Short in vitro half-life of thymopoietin 32-36 pentapeptide in human plasma[J].Int JPharm,1979,14:479-484.
  • 2Paolo C,Francesco M V.Pharmacokinetic and biodistribution prop-erties of poly(ethylene glycol)-protein conjugates[J].Adv DrugDeliver Rev,2003,55:1261-1277.
  • 3Gerd G K.Site-specific polymer modification of therapeutic pro-teins[J].Curr Opin Chem Biol,2005,9:555-560.
  • 4DeGraw J I,Almquist G,Hiebert C K,et al.Stabilized analogs oftymopentin.1.4,5-Ketomethylene pseudopeptides[J].J MedChem,1997,40(15):2386-2397.
  • 5De Graw J I,Almquist R G,Hiebert C K,et al.Stabilized analogsof thymopentin.2.1,2-and 4,5-Ketomethylene pseudopeptides[J].J Med Chem,1997,40(2)15:2398-2406.
  • 6李倩,马亚平,王长林,张颍锴,倪京满.采用固-液相相结合法合成聚乙二醇化胸腺五肽[J].中国生化药物杂志,2010,31(5):289-292. 被引量:2
  • 7付正明,王洪权,丁建新,窦媛媛.蛋白质多肽药物聚乙二醇定点修饰的研究进展[J].军事医学科学院院刊,2007,31(2):178-182. 被引量:5
  • 8Hamidi M,Azadi A,Rafiei P.Pharmacokinetic consequences of pe-gylation[J].Drug Deliv,2006,13(6):399-409.

二级参考文献42

  • 1王良友,潘和平,柳川,高亚萍.人甲状旁腺素(1-34)的合成与聚乙二醇化修饰[J].中国生化药物杂志,2005,26(2):76-79. 被引量:6
  • 2欧阳嘉,李鑫,潘宗敏,沈树宝.Fmoc(9-芴甲氧羰基)法固相合成胸腺五肽[J].南京工业大学学报(自然科学版),2005,27(3):61-64. 被引量:12
  • 3唐微,常远,徐 飞,郑仲承,刘新垣.蛋白质定点PEG化研究:97Cys-IFH-γ的巯基专—PEG修饰[J].生物化学与生物物理学报,1996,28(3):312-315. 被引量:5
  • 4Goldstein G,Scheid M P,Boyse E A,et al.A synthetic entapoptide with biological activity characteristic of the thymic hormone thymopoietin[J].Science,1979,204(4399):1309-1310.
  • 5Gonser S,Weber E,Folkers G.Peptides and polypeptides as modulators of the immune response:thymopentin-an example with unknown mode of action[J].Pharm Acta Hely,1999,73(6):265-273.
  • 6Tiachio J P,Patrick J E,Weintraub H S,et al.Short in vitro half-life of thymopoietin 32-36 pentapeptide in human plasma[J].Int J Pept Protein Res,1979,14(5):479-484.
  • 7Wang J,Lu W L,Liang G W,et al.Pharmacokinetics,toxicity of nasal cilia and immunomodulating effects in Sprague-Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers[J].Peptides,2006,27(4):826-835.
  • 8Ynan X J,Zhang Z R,Song Q G,et al.Research on thymopentin loaded oral N-trimethyl chitosan nanoparticles[J].Arch Pharm Res,2006,29(9):795-799.
  • 9Zheng A P,Wang J C,Lu W L,et al.Thymopentin-loaded pH-sensitive chitozen nanoparticles for oral administration:reparation,characterization,and pharmacodynamics[J].J Nanosci Nanotechnol,2006,6(9210):2936-2944.
  • 10YinY S,Chen D W,Qiao M X,et al.Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin[J].J Controlled Release,2006,116(3):337-345.

共引文献5

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部